{"transactions":[{"id":770362,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:13:21.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":4.52,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001587514-26-000009","document":"wk-form4_1779307998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000009/wk-form4_1779307998.xml","form_type":"4"}},{"id":770361,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:13:21.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001587514-26-000009","document":"wk-form4_1779307998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000009/wk-form4_1779307998.xml","form_type":"4"}},{"id":901710,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T23:22:16.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":21165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":21165},"source":{"system":"sec-edgar","filing":"0001587514-26-000007","document":"wk-form4_1771370533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000007/wk-form4_1771370533.xml","form_type":"4"}},{"id":901709,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-17T23:22:16.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":21165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 15, 2023, the reporting person was granted 127,000 restricted stock units. Eighty-four thousand, six hundred seventy (84,670) were vested prior to the reporting person's separation from the company and 21,165 units vested upon his separation on August 13, 2025 in accordance with his Separation Agreement."}],"balance_after":867240,"source":{"system":"sec-edgar","filing":"0001587514-26-000007","document":"wk-form4_1771370533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000007/wk-form4_1771370533.xml","form_type":"4"}},{"id":912600,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T23:17:18.000Z","date":"2026-02-08","kind":"exercise","planned":false,"acquired":false,"shares":15831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 8, 2024, the reporting person was granted 95,000 restricted stock units. One-third of the restricted stock units vested after one year and one-half of the remaining units vested pursuant to the reporting person's \"Separation Agreement\" on August 13, 2025. The remaining units vest in two equal installments on the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 8, 2024, the reporting person was granted 95,000 restricted stock units. One-third of the restricted stock units vested after one year and one-half of the remaining units vested pursuant to the reporting person's \"Separation Agreement\" on August 13, 2025. The remaining units vest in two equal installments on the anniversary of the grant date."}],"balance_after":15832,"derivative":{"underlying":"Common Stock","underlying_shares":15831},"source":{"system":"sec-edgar","filing":"0001587514-26-000004","document":"wk-form4_1770765435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000004/wk-form4_1770765435.xml","form_type":"4"}},{"id":912599,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T23:17:18.000Z","date":"2026-02-08","kind":"exercise","planned":false,"acquired":true,"shares":15831,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":846075,"source":{"system":"sec-edgar","filing":"0001587514-26-000004","document":"wk-form4_1770765435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751426000004/wk-form4_1770765435.xml","form_type":"4"}},{"id":1065686,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-15T21:05:12.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":31664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."}],"balance_after":31663,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31664},"source":{"system":"sec-edgar","filing":"0001587514-25-000005","document":"wk-form4_1755291908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751425000005/wk-form4_1755291908.xml","form_type":"4"}},{"id":1065685,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-15T21:05:12.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":21165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."}],"balance_after":21165,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":21165},"source":{"system":"sec-edgar","filing":"0001587514-25-000005","document":"wk-form4_1755291908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751425000005/wk-form4_1755291908.xml","form_type":"4"}},{"id":1065684,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T21:05:12.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":31664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":830244,"source":{"system":"sec-edgar","filing":"0001587514-25-000005","document":"wk-form4_1755291908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751425000005/wk-form4_1755291908.xml","form_type":"4"}},{"id":1065683,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T21:05:12.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":21165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Separation and Consulting Agreement between the Company and the Reporting Person (the \"Separation Agreement\"), 50% of the shares with respect to each outstanding and unvested restricted stock unit (RSU) immediately vested. Vested shares will be delivered to the Reporting Person as soon as practicable after the date of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":798580,"source":{"system":"sec-edgar","filing":"0001587514-25-000005","document":"wk-form4_1755291908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000158751425000005/wk-form4_1755291908.xml","form_type":"4"}},{"id":1261042,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T21:28:50.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":false,"shares":42329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":42330,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42329},"source":{"system":"sec-edgar","filing":"0001125345-25-000035","document":"wk-form4_1740000523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000035/wk-form4_1740000523.xml","form_type":"4"}},{"id":1261041,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-19T21:28:50.000Z","date":"2025-02-15","kind":"exercise","planned":false,"acquired":true,"shares":42329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":777415,"source":{"system":"sec-edgar","filing":"0001125345-25-000035","document":"wk-form4_1740000523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000035/wk-form4_1740000523.xml","form_type":"4"}},{"id":1274439,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T01:28:10.000Z","date":"2025-02-08","kind":"exercise","planned":false,"acquired":false,"shares":31673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":63327,"derivative":{"underlying":"Common Stock","underlying_shares":31673},"source":{"system":"sec-edgar","filing":"0001125345-25-000015","document":"wk-form4_1739323682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000015/wk-form4_1739323682.xml","form_type":"4"}},{"id":1274438,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-12T01:28:10.000Z","date":"2025-02-08","kind":"grant","planned":false,"acquired":true,"shares":31673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":735086,"source":{"system":"sec-edgar","filing":"0001125345-25-000015","document":"wk-form4_1739323682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000015/wk-form4_1739323682.xml","form_type":"4"}},{"id":1388698,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-09T20:26:37.000Z","date":"2024-10-07","kind":"gift","planned":false,"acquired":true,"shares":53265,"ownership":{"direct":false,"nature":"The Koenig 2024 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein."}],"balance_after":427480,"source":{"system":"sec-edgar","filing":"0001125345-24-000155","document":"wk-form4_1728505591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000155/wk-form4_1728505591.xml","form_type":"4"}},{"id":1388697,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-09T20:26:37.000Z","date":"2024-10-07","kind":"gift","planned":false,"acquired":false,"shares":53265,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001125345-24-000155","document":"wk-form4_1728505591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000155/wk-form4_1728505591.xml","form_type":"4"}},{"id":1399586,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-25T20:35:15.000Z","date":"2024-09-23","kind":"gift","planned":false,"acquired":true,"shares":374215,"ownership":{"direct":false,"nature":"The Koenig 2024 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership, and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein."}],"balance_after":374215,"source":{"system":"sec-edgar","filing":"0001125345-24-000153","document":"wk-form4_1727296509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000153/wk-form4_1727296509.xml","form_type":"4"}},{"id":1399585,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-25T20:35:15.000Z","date":"2024-09-23","kind":"gift","planned":false,"acquired":false,"shares":374215,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transfer is a gift which the reporting person believes was, in whole or in part, exempted by Rule 16a-13 as a change in form of beneficial ownership, and the reporting person disclaims beneficial ownership of shares held by the irrevocable trust except to the extent of his pecuniary interest therein."}],"balance_after":703413,"source":{"system":"sec-edgar","filing":"0001125345-24-000153","document":"wk-form4_1727296509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000153/wk-form4_1727296509.xml","form_type":"4"}},{"id":1531812,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-01T20:30:48.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.62,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-011872","document":"form4-05012024_080541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000141588924011872/form4-05012024_080541.xml","form_type":"4"}},{"id":1634682,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-20T23:04:58.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":false,"shares":42341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":84659,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42341},"source":{"system":"sec-edgar","filing":"0001125345-24-000040","document":"wk-form4_1708470288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000040/wk-form4_1708470288.xml","form_type":"4"}},{"id":1634681,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-20T23:04:58.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":14349,"price":17.4,"value":249672.6,"ownership":{"direct":true},"balance_after":1077628,"source":{"system":"sec-edgar","filing":"0001125345-24-000040","document":"wk-form4_1708470288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000040/wk-form4_1708470288.xml","form_type":"4"}},{"id":1634680,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-20T23:04:58.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":true,"shares":42341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis."}],"balance_after":1091977,"source":{"system":"sec-edgar","filing":"0001125345-24-000040","document":"wk-form4_1708470288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000040/wk-form4_1708470288.xml","form_type":"4"}},{"id":1649728,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-02-12T22:31:52.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter."}],"balance_after":95000,"derivative":{"underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001125345-24-000019","document":"wk-form4_1707777099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000019/wk-form4_1707777099.xml","form_type":"4"}},{"id":1649727,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-12T22:31:52.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":248000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter."}],"balance_after":248000,"derivative":{"exercise_price":18.3,"expiration_date":"2034-02-08","underlying":"Common Stock","underlying_shares":248000},"source":{"system":"sec-edgar","filing":"0001125345-24-000019","document":"wk-form4_1707777099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000019/wk-form4_1707777099.xml","form_type":"4"}},{"id":1869281,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-02T20:10:27.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested on May 18, 2023 and are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-23-033675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123033675/doc4.xml","form_type":"4"}},{"id":1869280,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:10:27.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":21000,"price":0.6,"value":12600.0,"ownership":{"direct":true},"balance_after":36750,"source":{"system":"sec-edgar","filing":"0001209191-23-033675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123033675/doc4.xml","form_type":"4"}},{"id":1882304,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:24:14.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-031456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123031456/doc4.xml","form_type":"4"}},{"id":2008287,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-17T21:32:38.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":127000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter."}],"balance_after":127000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":127000},"source":{"system":"sec-edgar","filing":"0001125345-23-000037","document":"wf-form4_167666948789460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000037/wf-form4_167666948789460.xml","form_type":"4"}},{"id":2008286,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-17T21:32:38.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter."}],"balance_after":510000,"derivative":{"exercise_price":4.82,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001125345-23-000037","document":"wf-form4_167666948789460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000037/wf-form4_167666948789460.xml","form_type":"4"}},{"id":2041983,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T21:13:27.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested on May 18, 2022 and are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.55,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-005471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123005471/doc4.xml","form_type":"4"}},{"id":2041982,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T21:13:27.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":10500,"price":2.55,"value":26775.0,"ownership":{"direct":true},"balance_after":15750,"source":{"system":"sec-edgar","filing":"0001209191-23-005471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123005471/doc4.xml","form_type":"4"}},{"id":2099891,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":2.17,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099890,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":4.72,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099889,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":3.02,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099888,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":6.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099887,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099886,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":7.75,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099885,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":6200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":16.06,"expiration_date":"2025-11-19","underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099884,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":4688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":20.83,"expiration_date":"2024-12-29","underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099883,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":12,"expiration_date":"2024-03-26","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099882,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":14285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":4.9,"expiration_date":"2023-09-18","underlying":"Common Stock","underlying_shares":14285},"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2099881,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T09:18:12.000Z","date":"2022-11-30","kind":"other","acquired":false,"shares":34246,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (1) $0.34 per share of common stock of the Issuer (\"Common Stock\"), without interest and less any applicable withholding taxes  (the \"Cash Consideration\"); and (2) one contingent value right (\"CVR\") per share of Common Stock representing the right to receive potential milestone payments, currently estimated to be up to approximately $0.73 per CVR in the aggregate (without interest and less any applicable withholding taxes) (the Cash Consideration plus one CVR, collectively, as such amount may be increased in accordance with the terms of the Merger Agreement, the \"Offer Price\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (1) $0.34 per share of common stock of the Issuer (\"Common Stock\"), without interest and less any applicable withholding taxes  (the \"Cash Consideration\"); and (2) one contingent value right (\"CVR\") per share of Common Stock representing the right to receive potential milestone payments, currently estimated to be up to approximately $0.73 per CVR in the aggregate (without interest and less any applicable withholding taxes) (the Cash Consideration plus one CVR, collectively, as such amount may be increased in accordance with the terms of the Merger Agreement, the \"Offer Price\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-023024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023024/form4.xml","form_type":"4"}},{"id":2261578,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:19:51.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-031007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122031007/doc4.xml","form_type":"4"}},{"id":2268565,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2022-05-17T21:20:28.000Z","date":"2022-05-16","kind":"exercise","acquired":false,"shares":53265,"price":1.51,"value":80430.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.51,"expiration_date":"2023-01-05","underlying":"Common Stock","underlying_shares":53265},"source":{"system":"sec-edgar","filing":"0001125345-22-000049","document":"wf-form4_165282239043395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000049/wf-form4_165282239043395.xml","form_type":"4"}},{"id":2268564,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-17T21:20:28.000Z","date":"2022-05-16","kind":"exercise","acquired":true,"shares":53265,"price":1.51,"value":80430.15,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The transaction represents an exercise and hold of options.  The shares are jointly owned with reporting person's spouse."}],"balance_after":1049636,"source":{"system":"sec-edgar","filing":"0001125345-22-000049","document":"wf-form4_165282239043395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000049/wf-form4_165282239043395.xml","form_type":"4"}},{"id":2375405,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2022-02-25T00:47:47.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter."}],"balance_after":480000,"derivative":{"exercise_price":10.15,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001125345-22-000029","document":"wf-form4_164575004704334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000029/wf-form4_164575004704334.xml","form_type":"4"}},{"id":2488452,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-02T18:52:33.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over one year from the date of grant."}],"balance_after":14000,"derivative":{"exercise_price":2.17,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-21-012055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299321012055/form4.xml","form_type":"4"}},{"id":2692868,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T00:49:05.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":10500,"derivative":{"exercise_price":2.55,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-036376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121036376/doc4.xml","form_type":"4"}},{"id":2692867,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T00:49:05.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001209191-21-036376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121036376/doc4.xml","form_type":"4"}},{"id":2836296,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2021-02-24T23:03:43.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter."}],"balance_after":280000,"derivative":{"exercise_price":19.18,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001125345-21-000026","document":"wf-form4_161420779282904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534521000026/wf-form4_161420779282904.xml","form_type":"4"}},{"id":2937621,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T17:10:06.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over one year from the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":4.72,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001273636-20-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363620000007/edgar.xml","form_type":"4"}},{"id":3133340,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T20:31:03.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-20-032308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919120032308/doc4.xml","form_type":"4"}},{"id":3211453,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2020-03-13T20:15:31.000Z","date":"2020-03-11","kind":"exercise","acquired":false,"shares":133163,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.94,"exercise_date":"2012-09-14","expiration_date":"2022-03-13","underlying":"Common Stock","underlying_shares":133163},"source":{"system":"sec-edgar","filing":"0001125345-20-000044","document":"wf-form4_158413051474478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000044/wf-form4_158413051474478.xml","form_type":"4"}},{"id":3211452,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-13T20:15:31.000Z","date":"2020-03-11","kind":"exercise","acquired":true,"shares":133163,"price":0.94,"value":125173.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The transaction represents an exercise and hold of options.  The shares are jointly owned with reporting person's spouse."}],"balance_after":943103,"source":{"system":"sec-edgar","filing":"0001125345-20-000044","document":"wf-form4_158413051474478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000044/wf-form4_158413051474478.xml","form_type":"4"}},{"id":3253515,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2020-02-24T21:45:49.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":290000,"price":11.5,"value":3335000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter."}],"balance_after":290000,"derivative":{"exercise_price":11.5,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001125345-20-000022","document":"wf-form4_158258073276662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000022/wf-form4_158258073276662.xml","form_type":"4"}},{"id":3349591,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-06T17:39:01.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable on December 4, 2020."}],"balance_after":10000,"derivative":{"exercise_price":3.02,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273636-19-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000041/edgar.xml","form_type":"4"}},{"id":3507395,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-30T16:04:22.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":32018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.35,"expiration_date":"2023-01-06","underlying":"Common Stock","underlying_shares":32018},"source":{"system":"sec-edgar","filing":"0001273636-19-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/edgar.xml","form_type":"4"}},{"id":3507394,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T16:04:22.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":32018,"price":0.35,"value":11206.3,"ownership":{"direct":true},"balance_after":34246,"source":{"system":"sec-edgar","filing":"0001273636-19-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/edgar.xml","form_type":"4"}},{"id":3516602,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-21T20:08:27.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.39,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-19-031720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919119031720/doc4.xml","form_type":"4"}},{"id":3636315,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2019-02-25T21:00:36.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter."}],"balance_after":260000,"derivative":{"exercise_price":21.88,"expiration_date":"2029-02-21","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001125345-19-000027","document":"wf-form4_155112842141714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000027/wf-form4_155112842141714.xml","form_type":"4"}},{"id":3705101,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2019-01-04T21:29:05.000Z","date":"2019-01-03","kind":"exercise","acquired":false,"shares":39897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents an exercise and hold of expiring options."}],"balance_after":0,"derivative":{"exercise_price":0.94,"exercise_date":"2009-07-11","expiration_date":"2019-01-10","underlying":"Common Stock","underlying_shares":39897},"source":{"system":"sec-edgar","filing":"0001125345-19-000002","document":"wf-form4_154663732415783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000002/wf-form4_154663732415783.xml","form_type":"4"}},{"id":3705100,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-04T21:29:05.000Z","date":"2019-01-03","kind":"exercise","acquired":true,"shares":39897,"price":0.94,"value":37503.18,"ownership":{"direct":true},"balance_after":213060,"source":{"system":"sec-edgar","filing":"0001125345-19-000002","document":"wf-form4_154663732415783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000002/wf-form4_154663732415783.xml","form_type":"4"}},{"id":3758662,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-19T19:18:15.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable on November 15, 2019."}],"balance_after":10000,"derivative":{"exercise_price":6.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273636-18-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000063/edgar.xml","form_type":"4"}},{"id":3765296,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2018-11-14T21:32:12.000Z","date":"2018-11-13","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents an exercise and hold of expiring options."}],"balance_after":39897,"derivative":{"exercise_price":0.94,"exercise_date":"2009-07-11","expiration_date":"2019-01-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001125345-18-000101","document":"wf-form4_154223111325336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000101/wf-form4_154223111325336.xml","form_type":"4"}},{"id":3765295,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-14T21:32:12.000Z","date":"2018-11-13","kind":"exercise","acquired":true,"shares":40000,"price":0.94,"value":37600.0,"ownership":{"direct":true},"balance_after":173163,"source":{"system":"sec-edgar","filing":"0001125345-18-000101","document":"wf-form4_154223111325336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000101/wf-form4_154223111325336.xml","form_type":"4"}},{"id":3858953,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-30T21:15:58.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct a scrivener's error with regards to the number of shares underlying the option grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable on July 25, 2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 is being amended to correct a scrivener's error with regards to the number of shares underlying the option grant."}],"balance_after":10000,"derivative":{"exercise_price":4.25,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273636-18-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000038/edgar.xml","form_type":"4/A","original_submission_date":"2018-07-27"}},{"id":3859879,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-27T17:37:19.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable on July 25, 2019."}],"balance_after":8000,"derivative":{"exercise_price":4.25,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001273636-18-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000028/edgar.xml","form_type":"4"}},{"id":3923699,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T20:17:34.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":18.41,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-18-031825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919118031825/doc4.xml","form_type":"4"}},{"id":4011573,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2018-03-06T22:23:34.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":28.94,"expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001125345-18-000042","document":"wf-form4_152037499084075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000042/wf-form4_152037499084075.xml","form_type":"4"}},{"id":4301031,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-30T20:09:47.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 25, 2018, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":13.89,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-17-036120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919117036120/doc4.xml","form_type":"4"}},{"id":4388344,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-13T20:09:02.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy.  The shares underlying this option vest in three equal installments on March 9, 2018, 2019 and 2020, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":22000,"derivative":{"exercise_price":6.59,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-17-020152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919117020152/doc4.xml","form_type":"4"}},{"id":4408926,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-03-02T19:19:27.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option becomes exercisable on February 28, 2018."}],"balance_after":8000,"derivative":{"exercise_price":7.75,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-17-006160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317006160/doc4.xml","form_type":"4"}},{"id":4443036,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-16T22:44:47.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":20.53,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001125345-17-000030","document":"wf-form4_148728507322958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000030/wf-form4_148728507322958.xml","form_type":"4"}},{"id":4486777,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-19T21:40:33.000Z","date":"2016-05-18","kind":"other","acquired":true,"shares":34619,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Scott Koenig Family Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"(2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share."}],"balance_after":167782,"source":{"system":"sec-edgar","filing":"0001125345-17-000004","document":"wf-form5_148486201690358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000004/wf-form5_148486201690358.xml","form_type":"5"}},{"id":4486776,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-19T21:40:33.000Z","date":"2016-05-17","kind":"other","acquired":true,"shares":79898,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Scott Koenig Family Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"(1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share."}],"balance_after":167782,"source":{"system":"sec-edgar","filing":"0001125345-17-000004","document":"wf-form5_148486201690358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000004/wf-form5_148486201690358.xml","form_type":"5"}},{"id":4486775,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-19T21:40:33.000Z","date":"2016-05-18","kind":"other","acquired":false,"shares":34619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"(2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share."}],"balance_after":53265,"source":{"system":"sec-edgar","filing":"0001125345-17-000004","document":"wf-form5_148486201690358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000004/wf-form5_148486201690358.xml","form_type":"5"}},{"id":4486774,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-19T21:40:33.000Z","date":"2016-05-17","kind":"other","acquired":false,"shares":79898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"(1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"(1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share."}],"balance_after":53265,"source":{"system":"sec-edgar","filing":"0001125345-17-000004","document":"wf-form5_148486201690358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000004/wf-form5_148486201690358.xml","form_type":"5"}},{"id":4486769,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee stock option (right to buy)","published_at":"2017-01-19T21:40:15.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":79898,"price":0.94,"value":75104.12,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.94,"exercise_date":"2008-05-16","expiration_date":"2017-11-15","underlying":"Common Stock","underlying_shares":79898},"source":{"system":"sec-edgar","filing":"0001125345-17-000003","document":"wf-form4_148486200205855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000003/wf-form4_148486200205855.xml","form_type":"4"}},{"id":4486768,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":45754,"kind":"person","name":"Koenig Scott","position":1,"cik":"0001587514","reported_name":"Koenig Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-19T21:40:15.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":79898,"price":0.94,"value":75104.12,"ownership":{"direct":true},"balance_after":133163,"source":{"system":"sec-edgar","filing":"0001125345-17-000003","document":"wf-form4_148486200205855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000003/wf-form4_148486200205855.xml","form_type":"4"}}]}